Mohan Pankaj
- SEC CIK
- 0001664386
No open-market purchases or sales filed in the past year.
Current role at each company
- SONN Sonnet BioTherapeutics Holdings, Inc.Chairman, President and CEOas of Dec 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mohan Pankaj as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2023 (view filing) | Oct 27 | Same day | Mohan PankajChairman, President and CEO | PPurchase | +34.4K | – | – | +136.7%59.5K after | |
| Oct 27, 2023 (view filing) | Oct 27 | Same day | Mohan PankajChairman, President and CEO | PPurchase | +68.8K | – | – | –68.8K after | Derivative |
| May 15, 2023 (view filing)5:17 PM ET | May 15 | Same day | Mohan PankajChairman, President and CEO | PPurchase | +371.6K | $0.223 | +$82.9K | +204.5%553.3K after | |
| Mar 16, 2023 (view filing) | Mar 15 | 1 day | Mohan PankajChairman, President and CEO | PPurchase | +60.0K | $0.59 | +$35.4K | +49.3%181.7K after |